Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Molecular Immunology|August 1, 2006
Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activationV Michael Holers, Liudmila KulikMolecular Immunology|January 29, 2011
Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonistsLiudmila Kulik, Kuan Chen, Brigitte T Huber, et al.Molecular Immunology|April 5, 2023
Highly pathogenic natural monoclonal antibody B4-IgM recognizes a post-translational modification comprised of acetylated N-terminal methionine followed by aspartic or glutamic acidLiudmila Kulik, Brandon Renner, Jennifer Laskowski, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigensLouise Birrell, Liudmila Kulik, B Paul Morgan, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemiaKevin J Marchbank, Liudmila Kulik, Matthew G Gipson, et al.Molecular Immunology|December 3, 2014
A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and diseaseLiudmila Kulik, Finnegan B Hewitt, Van C Willis, et al.Plos Pathogens|May 5, 2022
Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1)Lucy Gordon, Neil Mabbott, Joanna Wells, et al.Seminars in Immunology|June 11, 2016
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalitiesV Michael Holers, Stephen Tomlinson, Liudmila Kulik, et al.Molecular Immunology|February 4, 2009
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)Isabel Y Pappworth, Liudmila Kulik, Catherine Haluszczak, et al.Journal of Neuroinflammation|June 21, 2017
Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complementAarti Narang, Fei Qiao, Carl Atkinson, et al.Pageof 4